Heterologous Ad26.COV2.S Prime and mRNA-Based Boost COVID-19 Vaccination Regimens: The SWITCH Trial Protocol.

ABSTRACT:

SUBMITTER: Sablerolles RSG 

PROVIDER: S-EPMC8529966 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature